IntroductionStreamlining product development processes is becoming a major priority for pharmaceutical manufacturers looking to improve their market share, and respond to growing regulatory pressure and competition.
This Datamonitor model forecasts the IT opportunity for PLM software and services for vendors targeting the life sciences.ScopeHighlightsReasons to PurchaseMonitor shifts in IT investments for PLM by the pharmaceutical industry Identify the most promising geographic segments of the pharmaceutical industry for your company's offerings Understand high-level shifts and implications in the Big Pharma and Biotech sectors